Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Current evidence is insufficient to fully endorse regenerative therapies for hair loss.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

There is not enough evidence to support health claims about soy isoflavones.

There is no strong evidence that chemopreventive agents effectively prevent prostate cancer.

Not enough evidence to support using platelet rich plasma for hair loss treatment.

There is not enough evidence to know if different ways of putting in eye drops for glaucoma work better than others.

There's not enough evidence to prove platelet-rich plasma works for facial rejuvenation.

"Medical marijuana" lacks strong evidence for medical use and is often a way to bypass recreational marijuana laws.

Mesotherapy lacks strong evidence for effectiveness and safety, and its ingredients are not FDA-approved for subcutaneous use.

Clinicians should use evidence-based tools and consider mental health when assessing alopecia areata to guide treatment.

No high-certainty evidence supports any specific acne treatment.

Personalized care and evidence-based treatments are crucial for managing skin and hair conditions.

There is not enough evidence to recommend multivitamin-mineral supplements and herbal treatments for alopecia areata.

No conclusive evidence links topical minoxidil to heart rhythm issues.

No clear evidence links green tea to hair loss through iron deficiency.

Fenugreek seeds lack strong evidence for treating hair loss.

No systemic treatment for alopecia areata has strong evidence of effectiveness.

Antiandrogen therapy for hidradenitis suppurativa lacks strong evidence and needs more research.

Mesotherapy for hair loss lacks evidence of effectiveness and safety and should not be used without further scientific support.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

Most emerging dermatological treatments lack strong evidence and require more research.

Most trichological shampoo ingredients lack strong evidence for effectiveness against hair loss.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

Mesotherapy for hair loss lacks strong evidence and clear guidelines for its effectiveness and product use.

Many hair loss myths lack strong evidence, but some treatments are proven to work.

PRP therapy shows promise for anti-aging but lacks consistent evidence and standardization.

The document concludes that better research methods are needed in men's sexual health to provide stronger evidence and improve patient care.

Most over-the-counter hair loss treatments lack strong evidence of effectiveness and are not FDA-approved.